Autologous bone marrow derived stem cells (DaVinci Biosciences)

自体骨髓源干细胞(Davinci Biosciences)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAutologous bone marrow derived stem cells (DaVinci Biosciences)
Drug Alias NameDV-1
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesDavinci Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDavinci Biosciences
Active IndicationsN/A
Inactive IndicationsSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksN/A